Over a decade of experience in neurodegenerative disease research, RNA biology, and therapeutic discovery, including a Ph.D. in Cellular, Molecular, and Biomedical Studies from Columbia University and postdoctoral fellowships at Columbia University and the University of Colorado Boulder (Howard Hughes Medical Institute). Her work spans mechanistic RNA biology, tau pathology, and translational neurodegeneration research, with a strong focus on identifying and validating therapeutic targets across spinal muscular atrophy and tauopathies. She has pioneered new strategies for modulating tau aggregation and neurotoxicity, resulting in multiple patents, first-author publications in Neuron, Genes & Development, and Nature Neuroscience.